Unknown

Dataset Information

Strategy for Extending Half-life in Drug Design and Its Significance.


ABSTRACT: Preclinical optimization of compounds toward viable drug candidates requires an integrated understanding of properties that impact predictions of the clinically efficacious dose. The importance of optimizing half-life, unbound clearance, and potency and how they impact dose predictions are discussed in this letter. Modest half-life improvements for short half-life compounds can dramatically lower the efficacious dose. The relationship between dose and half-life is nonlinear when unbound clearance is kept constant, whereas the relationship between dose and unbound clearance is linear when half-life is kept constant. Due to this difference, we show that dose is more sensitive to changes in half-life than changes in unbound clearance when half-lives are shorter than 2 h. Through matched molec

SUBMITTER: Gunaydin H 

PROVIDER: S-EPMC6004573 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature